SCHEMBL18255772

SCHEMBL18255772

Cc1cc(CCCCn2c(=O)c3c(ncn3C)n(C)c2=O)on1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 7/20 0.57
TNF P01375 4/20 0.57
PDE4A P27815 2/20 0.57
PDE4B Q07343 2/20 0.57
PDE4C Q08493 2/20 0.57
PDE4D Q08499 2/20 0.57
USP2 O75604 1/20 0.57
LMNA P02545 1/20 0.57
CYP1A2 P05177 1/20 0.57
TSHR P16473 1/20 0.57
NFKB1 P19838 1/20 0.57
ACHE P22303 1/20 0.57
PMP22 Q01453 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
RXFP1 Q9HBX9 1/20 0.57
CHIT1 Q13231 1/20 0.52
CHIA Q9BZP6 1/20 0.52
AKR1B1 P15121 1/20 0.50
GLA P06280 1/20 0.49
BLM P54132 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18255771 0.97 ADORA2B (0.55) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL18255761 0.92 ADORA2B (0.53) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL18255892 0.88 PDE4A (0.50) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL18255895 0.87 TRPA1 (0.49) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL18255903 0.87 TRPA1 (0.47) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL18255906 0.87 PDE4A (0.60) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL18255907 0.86 PDE4A (0.53) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL18255884 0.86 LMNA (0.45) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL18255893 0.86 TRPA1 (0.43) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL18255904 0.85 LMNA (0.45) ADORA2BTNFPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10278973-B2 Hydroxyl purine compounds and use thereof Guangdong Raynovent Biotech Co., Ltd. (CN) 2019-05-07 US disclosed
US-10278973-B2 Hydroxyl purine compounds and use thereof Guangdong Raynovent Biotech Co., Ltd. (CN) 2019-05-07 US disclosed
US-20180140607-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF Guangdong Raynovent Biotech Co., Ltd. (CN) 2018-05-24 US disclosed
US-20180140607-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF Guangdong Raynovent Biotech Co., Ltd. (CN) 2018-05-24 US disclosed
EP-3299371-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-03-28 EP disclosed
EP-3299371-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-03-28 EP disclosed
WO-2016184312-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF 南京明德新药研发股份有限公司 2016-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180140607-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF PNP, PDE7A, PDE2A ADORA2B 89/4885TNF 103/4885PDE4A 8/4885
US-10278973-B2 Hydroxyl purine compounds and use thereof PNP, PDE7A, PDE2A ADORA2B 89/4885TNF 103/4885PDE4A 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.